Acarix A/S (ACARIX) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.030x

Based on the latest financial reports, Acarix A/S (ACARIX) has a cash flow conversion efficiency ratio of 0.030x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.11 Million ≈ $119.78K USD) by net assets (Skr36.95 Million ≈ $3.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ACARIX market cap overview for the company's overall valuation and market capitalisation.

Acarix A/S - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Acarix A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Acarix A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acarix A/S ranked by their cash flow conversion efficiency. See Acarix A/S (ACARIX) debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
RSL Electronics Ltd TA:RSEL	-0.017x
Helium Evolution Inc V:HEVI	-0.016x
PM Thoresen Asia Holdings PCL BK:PMTA	-0.084x
Pineapple Financial Inc. NYSE MKT:PAPL	-0.121x
eHealth Inc NASDAQ:EHTH	0.057x
Acuvi AB ST:ACUVI	0.000x
Tobii AB ST:TOBII	0.129x
Holaluz-Clidom S.A MC:HLZ	0.511x

Annual Cash Flow Conversion Efficiency for Acarix A/S (2014–2025)

The table below shows the annual cash flow conversion efficiency of Acarix A/S from 2014 to 2025. View Acarix A/S stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr38.17 Million ≈ $4.11 Million	Skr-48.38 Million ≈ $-5.21 Million	-1.268x	-51.52%
2024-12-31	Skr75.70 Million ≈ $8.15 Million	Skr-63.33 Million ≈ $-6.81 Million	-0.837x	+46.65%
2023-12-31	Skr51.88 Million ≈ $5.58 Million	Skr-81.37 Million ≈ $-8.76 Million	-1.568x	-8.55%
2022-12-31	Skr51.83 Million ≈ $5.58 Million	Skr-74.87 Million ≈ $-8.06 Million	-1.445x	-202.56%
2021-12-31	Skr100.54 Million ≈ $10.82 Million	Skr-48.01 Million ≈ $-5.17 Million	-0.477x	-6.90%
2020-12-31	Skr82.14 Million ≈ $8.84 Million	Skr-36.69 Million ≈ $-3.95 Million	-0.447x	+23.17%
2019-12-31	Skr76.60 Million ≈ $8.24 Million	Skr-44.53 Million ≈ $-4.79 Million	-0.581x	-32.32%
2018-12-31	Skr87.88 Million ≈ $9.46 Million	Skr-38.61 Million ≈ $-4.15 Million	-0.439x	-39.74%
2017-12-31	Skr128.94 Million ≈ $13.88 Million	Skr-40.54 Million ≈ $-4.36 Million	-0.314x	-439.92%
2016-12-31	Skr155.52 Million ≈ $16.74 Million	Skr-9.06 Million ≈ $-974.57K	-0.058x	+91.81%
2015-12-31	Skr12.14 Million ≈ $1.31 Million	Skr-8.63 Million ≈ $-928.83K	-0.711x	+48.48%
2014-12-31	Skr15.12 Million ≈ $1.63 Million	Skr-20.87 Million ≈ $-2.25 Million	-1.380x	--

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$27.09 Million

Skr251.75 Million SEK

Market Cap Rank

#24196 Global

#459 in Sweden

Share Price

Skr0.21

Change (1 day)

+2.66%

52-Week Range

Skr0.21 - Skr0.34

All Time High

Skr20.62